LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Cancer Profiling KEW, Inc. specializes in advanced genomic profiling solutions for cancer, offering targeted therapies based on tumor genetic profiles. This positions the company as a strong partner for clinical labs and hospitals aiming to enhance precision medicine offerings.

Expanding Market Access The company's strategic focus on partnering with molecular labs to implement CANCERPLEX® indicates opportunities to expand into community healthcare providers and smaller specialty clinics seeking comprehensive genomic testing.

Strong Industry Collaborations Collaborations with major organizations like Invitae and Herbal Essences demonstrate KEW's ability to adapt its genomic solutions across diverse sectors, opening doors for cross-industry sales and joint ventures in healthcare and consumer brands interested in genomic data.

Funding and Revenue Growth With a funding of $17 million and revenue estimates between $10 million and $25 million, KEW is scaling rapidly, presenting opportunities for sales professionals to position additional solutions or expanded service packages to existing clients as the company grows.

Technological Sophistication Using an advanced tech stack including next-generation sequencing and partnerships for genomic analysis, KEW offers cutting-edge solutions, making it an ideal target for organizations seeking to upgrade their genomic and diagnostic capabilities.

KEW, Inc. Tech Stack

KEW, Inc. uses 8 technology products and services including RSS, WordPress, Open Graph, and more. Explore KEW, Inc.'s tech stack below.

  • RSS
    Content Management System
  • WordPress
    Content Management System
  • Open Graph
    Content Management System
  • Shopify
    E-commerce
  • jQuery Mobile
    Mobile Frameworks
  • Divi
    Page Builders
  • WP Engine
    Platform As A Service
  • PHP
    Programming Languages

KEW, Inc.'s Email Address Formats

KEW, Inc. uses at least 1 format(s):
KEW, Inc. Email FormatsExamplePercentage
FLast@kewinc.comJDoe@kewinc.com
42%
First.Last@kewinc.comJohn.Doe@kewinc.com
14%
FirstL@kewinc.comJohnD@kewinc.com
2%
FLast@kewinc.comJDoe@kewinc.com
42%

Frequently Asked Questions

Where is KEW, Inc.'s headquarters located?

Minus sign iconPlus sign iconKEW, Inc.'s main headquarters is located at 840 Memorial Drive 4th Floor Cambridge, Massachusetts 02139 United States. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is KEW, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact KEW, Inc.'s main corporate office by phone at
+1-617-229-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is KEW, Inc.'s official website and social media links?

Minus sign iconPlus sign iconKEW, Inc.'s official website is kewinc.com and has social profiles on LinkedInCrunchbase.

What is KEW, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconKEW, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does KEW, Inc. have currently?

Minus sign iconPlus sign iconAs of April 2026, KEW, Inc. has approximately 22 employees across 6 continents, including North AmericaAsiaEurope. Key team members include Strategic Account Manager: B. B.Manager: A. R.Human Resources Manager: C. J.. Explore KEW, Inc.'s employee directory with LeadIQ.

What industry does KEW, Inc. belong to?

Minus sign iconPlus sign iconKEW, Inc. operates in the Biotechnology Research industry.

What technology does KEW, Inc. use?

Minus sign iconPlus sign iconKEW, Inc.'s tech stack includes RSSWordPressOpen GraphShopifyjQuery MobileDiviWP EnginePHP.

What is KEW, Inc.'s email format?

Minus sign iconPlus sign iconKEW, Inc.'s email format typically follows the pattern of FLast@kewinc.com. Find more KEW, Inc. email formats with LeadIQ.

How much funding has KEW, Inc. raised to date?

Minus sign iconPlus sign icon As of April 2026, KEW, Inc. has raised $17M in funding. The last funding round occurred on Jan 12, 2015 for $17M.

When was KEW, Inc. founded?

Minus sign iconPlus sign iconKEW, Inc. was founded in 2011.

KEW, Inc.

Biotechnology ResearchMassachusetts, United States11-50 Employees

KEW, Inc. is a comprehensive genomic profiling company, dedicated to revolutionizing cancer care by providing therapeutic options based on an individual patient’s tumor genetic profile with CANCERPLEX®, our flagship clinical product for identifying genetic variants and matching them with targeted therapies in solid tumors. Based in Cambridge, MA, KEW was founded by pioneers of the precision medicine industry, including key contributors to the Human Genome and The Cancer Genome Atlas projects.

As increasing evidence puts precision medicine at the forefront in the fight against cancer, we have recognized the growing need for expanded patient access to comprehensive genomic profiling to guide better treatment decisions and quality patient care in local community practice. To address this critical, unmet need, we are now partnering with and enabling molecular labs to expand their precision medicine programs to adopt CANCERPLEX® for optimal cancer care in their local laboratories.

We couldn't have done it without our top-notch staff. You can view all of our career opportunities at www.kewinc.com/careers

Section iconCompany Overview

Headquarters
840 Memorial Drive 4th Floor Cambridge, Massachusetts 02139 United States
Phone number
+1-617-229-****
Website
kewinc.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $17M

    KEW, Inc. has raised a total of $17M of funding over 2 rounds. Their latest funding round was raised on Jan 12, 2015 in the amount of $17M.

  • $10M$25M

    KEW, Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $17M

    KEW, Inc. has raised a total of $17M of funding over 2 rounds. Their latest funding round was raised on Jan 12, 2015 in the amount of $17M.

  • $10M$25M

    KEW, Inc.'s revenue is estimated to be in the range of $10M$25M

Company Leadership

  • Stylized image of a person
    B. B.
    Strategic Account Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. R.
    Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. J.
    Human Resources Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. T.
    Senior Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. M.
    Credit Control Manager
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    T. H.
    Territory Business Manager, Oncology Next-Gen Sequencing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. M.
    Laboratory Logistics Associate
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. S.
    Accessories Designer And Buyer
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.